- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Poor Guidelines Compliance Suspected Cause of Most Metastatic GCT Relapses
A retrospective study suggests that the majority of cases of metastatic germ cell tumor (GCT) relapse are due primarily to poor conformity to international treatment guidelines, not to aggressive tumor biology (Abstract 323). This is sobering news considering that 80% of patients with metastatic GCT can be cured when treated appropriately.
The study focused on 78 patients with metastatic GCT that progressed after initial chemotherapy, all of whom were referred to the Institut Gustave Roussy in France between 2000 and 2010 for additional care.
Strikingly, only about half of these individuals (49%) received first-line treatment in accord with international treatment guidelines that were available at the time of disease diagnosis. The most common violations included delays between the delivery of chemotherapy cycles and the indication and timing of postchemotherapy surgery.
Guidelines compliance was markedly higher among patients initially treated at cancer centers as opposed to public or private hospitals (71% vs. 22%, respectively; p = 0.00001). In fact, the only independent predictive factor for guidelines compliance identified was the type of original treatment center (p = 0.00005).
Read more about the study at:http://tinyurl.com/83tshh6
Source: OBR Daily.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
